Analysis of neutralizing and enhancing antibodies to human immunodeficiency virus type 1 primary isolates in plasma of individuals infected with env genetic subtype B and E viruses in Thailand

Viral Immunology

Volumn 9, Issue 3, 1996, Pages 175-185

  Auewarakul, Prasert ^a,b   Louisirirotchanakul, Suda ^a   Sutthent, Ruengpung ^a   Taechowisan, Thongchai ^a   Kanoksinsombat, Chinda ^a   Wasi, Chantapong ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; NEUTRALIZING ANTIBODY;

ADULT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; PLASMA; PREGNANCY; THAILAND; VIRAL GENETICS; VIRUS ISOLATION; VIRUS STRAIN;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0029833150     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.1996.9.175     Document Type: Article

References (67)

1. Berman, P.W., K.K. Murthy, T. Wrin, J.C. Vennari, E.K. Cobb, D.J. Eastman, M. Champe, G.R. Nakamura, D. Davidson, M.F. Powell, J. Bussiere, D.P. Francis, T. Matthews, T.J. Gregory, and J.F. Obijeski. 1996. Protection of MN-rgp 120 immunized chimpanzees from heterologous infection with primary isolate of human immunodeficiency virus type 1. J. Infect. Dis. 173:52-59.
2. Bobkov, A., R. Cheingsong-Popov, M. Garaev, A. Rzhaninova, P. Kaleebu, S. Beddows, M.H. Bachmann, J.I. Mullins, J. Louwagie, W. Janssens, G. van der Groen, F. McCutchan, and J. Weber. 1994. Identification of an env G subtype and heterogeneity of HIV-1 strains in Russian Federation and Belarus. AIDS 8:1649-1655.
3. Bruck, C., C. Thiriart, L. Fabry, M. Francotte, P. Pala, O. Van Opstal, J. Culp, M. Rosenberg, M. De Wilde, P. Heidt, and J. Heeney. 1994. HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees. Vaccine 12:1141-1148.
4. Cao, Y., L. Qin, L. Zhang, J. Safrit, and D.D. Ho. 1995. Virologie and immunologie characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332:201-208.
5. Cheingsong-Popov, R., D. Callow, S. Beddows, S. Shaunak, C. Wasi, P. Kaleebu, C. Gilks, I.V. Petrascu, M.M. Garaev, D.M. Watts, N.T. Constantine, and J.N. Weber. 1992. Geographic diversity of human immunodeficiency virus type 1: Serologic reactivity to env epitopes and relationship to neutralization. J. Infect. Dis. 165:256-261.
6. Cheng-Mayer, C., J. Homsy, L.A. Evans, and J.A. Levy. 1988. Identification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization. Proc. Natl. Acad. Sci. U.S.A. 85:2815-2819.
7. Cheng-Mayer, C., D. Seto, M. Tateno, and J.A. Levy. 1988. Biological features of HIV-1 that correlate with virulence in host. Science 240:80-82.
8. de Wolf, F., E. Hogervorst, J. Goudsmit, E.M. Fenyö, H. Rübsamen-Waigmann, H. Holmes, B. Galvao-Castro, E. Karita, C. Wasi, S.D.K. Sempala, E. Baan, F. Zorgdrager, V. Lukashov, S. Osmanov, C. Kuiken, M. Cornelissen, and the WHO Network for HIV Isolation and Characterization. 1994. Syncytium-inducing and non-syncytium inducing capacity of human immunodeficiency virus type 1 subtypes other than B: Phenotypic and genotypic characteristics. AIDS Res. Hum. Retroviruses 10:1387-1400.
9. Delwart, E.L., E.G. Shpaer, J. Louwagie, F.E. McCutchan, M. Grez, H. Rubsamen-Waigmann, and J.I. Mullins. 1993. Genetic relationships determined by a DNA heteroduplex mobility assay: Analysis of HIV-1 env genes. Science 262:1257-1261.
10. Dumitrescu, O., M.L. Kalish, S.C. Kliks, C.I. Bandea, and J.A. Levy. 1994. Characterization of human immunodeficiency virus type 1 isolates from children in Romania: Identification of a new envelope subtype. J. Infect. Dis. 169:281-288.
11. Fenyö, E.M., L. Morfeldt-Månson, F. Chiodi, B. Lind, A. von Gegerfelt, J. Albert, E. Olausson, and B. Äsjö. 1988. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J. Virol. 62:4414-4419.
12. Fouchier, R.A., M. Groenink, N.A. Kootstra, M. Tersmette, H.G. Huisman, F. Miedema, and H. Schuitemaker. 1992. Phenotype-associated sequence variation in third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J. Virol. 66:3183-3187.
13. Girard, M., B. Meignier, F. Barré-Sinoussi, M.-P. Kieny, T. Matthews, E. Muchmore, P.L. Nara, Q. Wei, L. Rimsky, K. Weinhold, and P. Fultz. 1995. Vaccine-induced protection of chimpanzees against infection by heterologous human immunodeficiency virus type 1. J. Virol. 69:6239-6248.
14. Goudsmit, J., C. Debouck, R.H. Meloen, L. Smit, M. Bakker, D.M. Asher, A.V. Wolff, C.J. Gibbs, and C. Gajdusek. 1988. Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proc. Natl. Acad. Sci. U.S.A. 85:4478-4482.
15. Gürtler, L.G., P.H. Hauser, J. Eberle, A. von Braun, S. Knapp, L. Zekeng, J.M. Tsague, and L. Kaptue, 1994. A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J. Virol. 68:1581-1585.
16. Halstead, S.B. 1982. Immune enhancement of viral infection. Progr. Allergy 31:301-364.
17. Ho, D.D., J.A. McKeating, X.L. Li, T. Moudgil, E.S. Daar, N.-C. Sun, and J.E. Robinson. 1991. Conformational epitope on gp120 important to CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody. J. Virol. 65:489-493.
18. Hogervorst, E., J. de Jong, A. van Wijk, M. Bakker, M. Valk, P. Nara, and J. Goudsmit. 1995. Insertion of primary syncytium-inducing (SI) and non-SI envelope V3 loops in human immunodeficiency virus type 1 (HIV-1) LAI reduces neutralization sensitivity to autologous but not heterologous, HIV-1 antibodies. J. Virol. 69:6342-6351.
19. Homsy, J., M. Meyer, M. Tateno, S. Clarkson, and J.A. Levy. 1989. The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells. Science 244:1357-1360.
20. Homsy, J., M. Meyer, and J.A. Levy. 1990. Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals. J. Virol. 64:1437-1440.
21. Ichimura, H., S.C. Kliks, S. Visrutaratna, C.Y. Ou, M.L. Kalish, and J.A. Levy. 1994. Biological serological, and genetic characterization of HIV-1 subtype E isolates from northern Thailand. AIDS Res. Hum. Retroviruses 10:263-269.
22. Janssens, W., L. Heyndrickx, K. Fransen, J. Motte, M. Peeters, J.N. Nkengasong, P.M. Ndumbe, E. Delapore, J.-L. Perret, C. Atende, P. Piot, and G. van der Groen, 1994. Genetic and phylogenetic analysis of env subtypes G and H in Central Africa. AIDS Res. Hum. Retroviruses 10:877-879.
23. Kalish, M.L., A. Baldwin, S. Raktham, C. Wasi, C.C. Luo, G. Schochetman, T.D. Mastro, N. Young, S. Vanichseni, H. Rubsamen-Waigmann, H. von Briesen, J.I. Mullin, E. Delwart, B. Herring, J. Esparza, W.L. Heyward, and S. Osmanov. 1995. The evolving molecular epidemiology of HIV-1 envelope subtypes in injecting drug users in Bangkok, Thailand: Implications for HIV vaccine trials. AIDS 9:851-857.
24. Kliks, S.C., T. Shioda, N.L. Haigwood, and J.A. Levy. 1993. V3 variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 1. Proc. Natl. Acd. Sci. U.S.A. 90:11518-11522.
25. Kostrikis, L.G., E. Bagdades, Y. Cao, L. Zhang, D. Dimitriou, and D.D. Ho. 1995. Genetic analysis of human immunodeficiency virus type 1 from patients in Cyprus: Identification of a new subtype, designated subtype I. J. Virol. 69:6122-6130.
26. Kostrikis, L.G., Y. Cao, H. Ngai, J.P. Moore, and D.D. Ho. 1996. Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: Lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement. J. Virol. 70:445-458.
27. La Rosa, G.J., J.P. Davide, K. Weinhold, J.A. Waterbury, A.T. Profy, J.A. Lewis, A.J. Langlois, G.R. Dreesman, R.N. Boswell, P. Shadduck, L.H. Holley, M. Karplus, D.P. Bolognesi, T.J. Matthews, E.A. Emini, and S.D. Putney. 1990. Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science 249:932-935.
28. Levy, J.A. 1994. Humoral and cell-mediated immune response to HIV infection, Pp. 153-174. In J.A. Levy (ed.): HIV and the pathogenesis of AIDS. ASM Press, Washington, DC.
29. Louwagie, J., F.E. McCutchan, M. Peeters, T.P. Brennan, E. Sanders-Buell, G.A. Eddy, G. van der Groen, K. Fransen, G.-M. Gershey-Damet, R. DeLeys, and D.S. Burke. 1993. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS 7:769-780.
30. Mascola, J.R., B.J. Mathieson, P.M. Zack, M.C. Walker, S.B. Halstead, and D.S. Burke. 1993. Summary report: Workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials. AIDS Res. Hum. Retroviruses 9:1175-1184.
31. Mascola, J.R., J. Louwagie, F.E. McCutchan, C.L. Fischer, P.A. Hegerich, K.F. Wagner, A.K. Fowler, J.G. McNell, and D.S. Burke. 1994. Two antigenically distinct subtypes of human immunodeficiency virus type 1: Viral genotype predicts neutralization serotype. J. Infect. Dis. 169:48-54.
32. McCutchan, F.E., P.A. Hegerich, T.P. Brennen, P. Phanupak, P. Singharaj, A., Jugsudee, P.W. Berman, A.M. Gray, A.K. Fowler, and D.S. Burke. 1992. Genetic variants of HIV-1 in Thailand. AIDS Res. Hum. Retroviruses 8:1887-1895.
33. McDougal, J.S., S.P. Cort, M.S. Kennedy, C.D. Cabridilla, P.M. Feorino, D.P. Francis, D. Hicks, V.S. Kalyanaraman, and L.S. Martin. 1985. Immunoassay for detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV). J. Immunol. Methods 76:171-183.
34. Matthews, T.J. 1994. Dilemma of neutralization resistance of HIV-1 field isolates and vaccine development. AIDS Res. Hum. Retroviruses 10:631-632.
35. Moore, J.P., and P.L. Nara. 1991. The role of the V3 loop of gp120 in HIV infection. AIDS 5(suppl. 2):S21-S33.
36. Moore, J.P., and D.D. Ho. 1993. Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans. J. Virol. 67:863-875.
37. Moore, J.P., and D.D. Ho. 1995. HIV-1 neutralization: The consequence of viral adaptation to growth on transformed T-cells. AIDS 9:S117-S136.
38. Moore, J.P., Y. Cao, J. Leu, L. Qin, B. Korber, and D.D. Ho. 1996. Inter and intra-clade neutralization of human immunodeficiency virus type 1: Genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes. J. Virol. 70:427-444.
39. Muster, T., F. Steindl, M. Purtscher, A. Trkola, A. Klima, G. Himmler, F. Ruker, and H. Katinger. 1993. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J. Virol. 67:6642-6647.
40. Myers, G., B.T.M. Korber, J.A. Berzofsky, R.F. Smith, and G.N. Pavlakis. 1994. Human retroviruses and AIDS. Los Alamos National Laboratory, Los Alamos, New Mexico.
41. Nkengasong, J.N., M. Peeters, P. Ndumbe, W. Janssens, B. Willems, K. Fransen, M. Ngolle, P. Piot, and G. van der Groen. 1994. Cross-neutralizing antibodies to HIV-1 ANT70 and HIV-1 IIIB in sera of African and Belgian HIV-1 infected individuals. AIDS 8:1089-1096.
42. Ou, C.Y., Y. Tabebe, C.C. Luo, M. Kalish, W. Auwanit, C. Bandea, N. de la Torre, J.L. Moore, G. Schochetman, S. Yamazaki, H.D. Gayle, N.L. Young, and B.G. Weniger. 1992. Wide distribution of two subtype of HIV-1 in Thailand. AIDS Res. Hum. Retroviruses 8:1471-1472.
43. Pau, C.P., S. Lee-Thomas, W. Auwanit, J.R. George, C.Y. Ou, B.S. Parekh, T.C. Granade, D.L. Holloman, S. Phillips, G. Schochetman, N.L. Young, Y. Takebe, H.D. Gayle, and B.G. Weniger. 1993. Highly specific V-3 peptide enzyme immunoassay for serotyping HIV-1 specimens from Thailand. AIDS 7:337-340.
44. Pau, C.P., B.G. Weniger, M. Kai, N.L. Young, G. Schochetman, and J.R. George. 1993. An improved peptide EIA for serotyping HIV-1 from Thailand. First National Conference on Human Retroviruses and Related Infections. Washington DC, December 1993 (Abstract 170).
45. Robertson, D.L., P.M. Sharp, F.E. McCutchan, and B.H. Hahn. 1995. Recombination in HIV-1. Nature (London) 374:124-126.
46. Robinson, W.E. Jr., D.C. Montefiori, W.M. Mitchell, A.M. Prince, H.J. Alter, G.R. Dreesman, and J.W. Eichberg. 1989. Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1 infected and passively immunized chimpanzees. Proc. Natl. Acad. Sci. U.S.A. 86:4710-4714.
47. Rübsamen-Waigmann, H., H. von Briesen, H. Holmes, A. Björndal, B. Korber, R. Esser, S. Ranjbar, P. Tomlinson, B. Galvao-Castro, E. Karita, S.D.K. Sempala, C. Wasi, S. Osmanov, E.M. Fenyö, and the WHO Network for HIV Isolation and Characterization. 1994. Standard conditions of virus isolation reveal biological variability of HIV-1 type 1 in different regions of the world. AIDS Res. Hum. Retroviruses 10:1401-1408.
48. Sabino, E.C., E.G. Shpaer, M.G. Morgado, B.T. Korber, R.S. Diaz, V. Bongertz, S. Cavalcante, B. Galvao-Castro, J.I. Mullins, and A. Mayer. 1994. Identification of human immunodeficiency virus type 1 envelope genes recombinant between B and F in two epidemiologically linked individuals from Brazil. J. Virol. 68:6340-6346.
49. Schutten, M., A.C. Anderweg, M.L. Bosch, and A.D. Osterhaus. 1995. Enhancement of infectivity of a non-syncytium inducing HIV-1 by sCD4 and by human antibodies that neutralize syncytium inducing HIV-1. Scand. J. Immunol. 41:18-22.
50. Sharp, P.M., D.L. Robertson, F. Gao, and B.H. Hahn. 1994. Origins and diversity of human immunodeficiency viruses. AIDS 4(suppl. 1):S27-S42.
51. Siebelink, K.H., E. Tijhaar, R.C. Huisman, W. Huisman, A. de Ronde, I.H. Darby, M.J. Francis, G.F. Rimmelzwaan, and A.D. Osterhaus. 1995. Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccine. J. Virol. 69:3704-3711.
52. Steimer, K.S., P.J. Klasse, and J.A. McKeating. 1991. HIV-1 neutralization directed to epitopes other than linear V3 determinants. AIDS 5(suppl. 2):S135-S143.
53. Sullivan, N., Y. Sun, J. Li, W. Hofmann, and J. Sodroski. 1995. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell passaged human immunodeficiency virus type 1 isolates. J. Virol. 69:4413-4422.
54. Takeda, A., C.U. Tuazon, and F.A. Ennis. 1988. Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science 242:580-583.
55. Tersmette, M., R.E.Y. De Goede, B.J. Al, I. Winkel, R. Gruters, H.T. Cuypers, H.G. Huisman, and F. Miedema. 1988. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: Frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J. Virol. 62:2026-2032.
56. Thali, M., C. Furman, D.D. Ho, J. Robinson, S. Tilley, A. Pinter, and J. Sodroski. 1992. Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein. J. Virol. 66:5635-5641.
57. Tilley, S.A., W.J. Honnen, M.E. Racho, T.-C. Chou, and A. Pinter. 1992. Synergistic neutralization of HIV-1 by human monoclonal antibodies against the V3 loop and CD4-binding site of gp120. AIDS Res. Hum. Retroviruses 8:461-467.
58. Trkola, A., A.B. Pomales, H. Yuan, B. Korber, P.J. Maddon, G.P. Allaway, H. Katinger, C.F. Barbas 3rd, D.R. Burton, D.D. Ho, and J. Moore. 1995. Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG. J. Virol. 69:6609-6617.
59. Vanden Haesevelde, M., J-L. De Court, R.J. De Leys, B. Vanderborght, G. van der Groen, G. van Heuverswijn, and E. Saman. 1994. Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate. J. Virol. 68:1586-1596.
60. von Briesen, H., R. Andreesen, and H. Rübsamen-Waigmann. 1990. Systematic classification of HIV-1 biological subtypes on lymphocytes and monocytes/macrophages. Virology 178:597-602.
61. Wang, S.Z., K.E. Rushlow, C.J. Issel, R.F. Cook, S.J. Cook, M.L. Raabe, Y.H. Chong, L. Costa, and R.C. Montelaro. 1994. Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein. Virology 199:247-251.
62. Wasi, C., B. Herring, S. Raktham, S. Vanichseni, T.D. Mastro, N.L. Young, H. Rubsamen-Waigmann, H. von Briesen, M.L. Kalish, C.C. Luo, C.P. Pau, A. Baldwin, J.I. Mullins, E.L. Delwart, J. Esparza, W.L. Heyward, and S. Osmanov. 1995. Determination of HIV-1 subtypes in injecting drug users in Bangkok, Thailand, using peptide-binding enzyme immunoassay and heteroduplex mobility assay: Evidence of increasing infection with HIV-1 subtype E. AIDS 9:843-849.
63. Weber, J., E.M. Fenyö, P. Nara, and the WHO Network for HIV Isolation and Characterization. 1996. Neutralization serotypes of HIV-1 field isolates are not predicted by genetic subtype (submitted).
64. Weniger, B.G., Y. Takebe, C.-Y. Ou, and S. Yamazaki. 1994. The molecular epidemiology of HIV in Asia. AIDS 8 (suppl. 2):S13-S28.
65. WHO Network for HIV Isolation and Characterization. 1994. HIV type 1 variation in World Health Organization-sponsored vaccine evaluation sites: genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains. AIDS Res. Hum. Retroviruses 10:1327-1343.
66. Wu, S.-C., J.L. Spouge, S.R. Conley, W.-P. Tsai, M.J. Merges, and P.L. Nara. 1995. Human plasma enhances the infectivity of primary human immunodeficiency virus type 1 isolates in peripheral blood mononuclear cells and monocyte-derived macrophages. J. Virol. 69:6054-6062.
67. Zolla-Pazner, S., J. O'Leary, S. Burda, M.K. Gomy, M. Kim, J. Mascola, and F.E. McCutchan. 1995. Serotyping of primary human immunodeficiency virus type 1 isolates from diverse geographic locations by flow cytometry. J. Virol. 69:3807-3815.